LifeSciences BC today announced that their President, Karimah Es Sabar will be leaving the organization in April of next year to pursue a new opportunity with the Centre for Drug Research and Development (CDRD) in Vancouver.

“My tenure at LifeSciences BC has been one of the most personally and professionally rewarding of my career,” said Es Sabar. “It has offered me the opportunity to work with truly some of the brightest and most passionate people – people who have supported and inspired me,” she remarked. “The time has come however for me to work on building BC’s life sciences sector from a new vantage point.”

Es Sabar was appointed President of LifeSciences BC in April of 2005, and since that time, has led the organization to new levels of success in supporting and representing the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Under her leadership, she ensured that the entire life sciences community and all life sciences sectors, from biopharmaceuticals and medical devices, to bioproducts and bioenergy, forest, agricultural and marine biotech, became integrated into the organization in order to ensure that no life sciences sector is working in isolation – that all sectors were able to come together in a comprehensive, complementary and coordinated fashion.

Dr. Simon Pimstone, Chair of LifeSciences BC commented, “Although we will greatly miss having Karimah’s vision and wisdom driving  LSBC, she will still continue to be an active contributor to the organization and to our life sciences community. On behalf of the Board, I thank Karimah for so ably leading LSBC for the past five years, and we wish her the utmost success in her new role.”

From January 1st, until her departure, Es Sabar will take on joint responsibilities with both LifeSciences BC and CDRD.  LSBC has initiated a search for a new President.